These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 14572556)
1. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge. Sterling RK Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556 [No Abstract] [Full Text] [Related]
2. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection. McGovern B Clin Infect Dis; 2007 Apr; 44(7):1012-3; author reply 1013. PubMed ID: 17342661 [No Abstract] [Full Text] [Related]
4. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy? Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656 [TBL] [Abstract][Full Text] [Related]
5. Routine hepatitis B virus DNA testing in patients with human immunodeficiency virus. Altinbas A; Ekiz F; Yuksel O Hepatology; 2010 Jul; 52(1):397. PubMed ID: 20578159 [No Abstract] [Full Text] [Related]
6. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040 [TBL] [Abstract][Full Text] [Related]
7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM; Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [TBL] [Abstract][Full Text] [Related]
8. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Stock PG; Fung J Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639 [No Abstract] [Full Text] [Related]
9. HIV-hepatitis C virus coinfection: questions and answers. Valenti WM AIDS Read; 2005 Mar; 15(3):110-2, 117, 127-8. PubMed ID: 15786572 [No Abstract] [Full Text] [Related]
10. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Verucchi G; Calza L; Manfredi R; Chiodo F Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741 [TBL] [Abstract][Full Text] [Related]
11. HCV and HIV: a tale of two viruses. Sherman KE Rev Gastroenterol Disord; 2004; 4 Suppl 1():S48-54. PubMed ID: 15185718 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. Kim AY; Chung RT; Polsky B AIDS Clin Rev; 2000-2001; ():263-306. PubMed ID: 10999223 [No Abstract] [Full Text] [Related]
13. Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously. Mazza C; Puoti M; Ravaggi A; Castelnuovo F; Albertini A; Cariani E J Med Virol; 1996 Nov; 50(3):276-82. PubMed ID: 8923294 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy. Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064 [TBL] [Abstract][Full Text] [Related]
15. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses]. Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066 [No Abstract] [Full Text] [Related]
16. British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. Wilkins E; Nelson M; Agarwal K; Awoyemi D; Barnes E; Bhagani S; Brook G; Brown A; Castelino S; Cooke G; Fisher M; Geretti AM; James R; Kulasegaram R; Leen C; Mutimer D; Orkin C; Page E; Palfreeman A; Papineni P; Rodger A; Tong CY; HIV Med; 2013 Nov; 14 Suppl 4():1-71. PubMed ID: 24581304 [No Abstract] [Full Text] [Related]
17. A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy. Vallabhaneni S; Kumarasamy N; Wing EJ; Flanigan TP AIDS Read; 2005 Feb; 15(2):72-5. PubMed ID: 15712396 [TBL] [Abstract][Full Text] [Related]
18. Viral hepatitis in HIV infection. Koziel MJ; Peters MG N Engl J Med; 2007 Apr; 356(14):1445-54. PubMed ID: 17409326 [No Abstract] [Full Text] [Related]
19. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation? Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851 [TBL] [Abstract][Full Text] [Related]
20. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]